Wenju F. Lu

State Key Laboratory Of Respiratory Disease, Guangdong Key Laboratory Of Vascular Disease
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 177 publications

Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension.

Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 14, 2026

The Effect of Anion Inhalation in a Mouse Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

The Effect of Anion Inhalation in a Mouse Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

Journal: COPD

Published: February 06, 2026

Neonatal Hyperoxia Induces Metabolic Reprogramming in Senescent Alveolar Macrophages, Leading to Persistent Lung Injury.

Neonatal Hyperoxia Induces Metabolic Reprogramming in Senescent Alveolar Macrophages, Leading to Persistent Lung Injury.

Journal: Frontiers in bioscience (Landmark edition)

Published: November 18, 2025

Characterization of hyperoxia-induced senescent lung macrophages in neonatal mice.

Characterization of hyperoxia-induced senescent lung macrophages in neonatal mice.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

MUC1 alleviates PM2.5-induced airway inflammation by inhibiting the IRAK4/NF-κB/NLRP3 mediated pyroptosis in airway epithelial cells.

MUC1 alleviates PM2.5-induced airway inflammation by inhibiting the IRAK4/NF-κB/NLRP3 mediated pyroptosis in airway epithelial cells.

Journal: Frontiers in immunology

Published: June 24, 2025

Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.

Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: June 06, 2025

GPIIb/IIIa-ICAM-1-Mediated Platelet-Endothelial Adhesion Exacerbates Pulmonary Hypertension.

GPIIb/IIIa-ICAM-1-Mediated Platelet-Endothelial Adhesion Exacerbates Pulmonary Hypertension.

Journal: American journal of respiratory cell and molecular biology

Published: February 28, 2025

Aging and lung diseases: Unraveling mechanisms and therapeutic targets.

Aging and lung diseases: Unraveling mechanisms and therapeutic targets.

Journal: Chinese medical journal pulmonary and critical care medicine

Published: February 24, 2025

Protective effects of estradiol on neuroinflammation in chronic obstructive pulmonary disease related depression.

Protective effects of estradiol on neuroinflammation in chronic obstructive pulmonary disease related depression.

Journal: Journal of thoracic disease

Published: February 07, 2025

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.

Journal: Respiratory research

Published: February 06, 2025

Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.

Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: January 06, 2025

Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.

Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 27, 2024

Showing 1-12 of 177

Last Updated: 09/26/2026